![](/img/cover-not-exists.png)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
Neoptolemos, John P, Palmer, Daniel H, Ghaneh, Paula, Psarelli, Eftychia E, Valle, Juan W, Halloran, Christopher M, Faluyi, Olusola, O'Reilly, Derek A, Cunningham, David, Wadsley, Jonathan, Darby, SuzVolume:
389
Language:
english
Journal:
The Lancet
DOI:
10.1016/s0140-6736(16)32409-6
Date:
March, 2017
File:
PDF, 485 KB
english, 2017